These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 36097121)
21. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples. Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347 [TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway. Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318 [No Abstract] [Full Text] [Related]
23. MiR-490-3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma. Ou Y; He J; Liu Y IUBMB Life; 2018 Jun; 70(6):468-478. PubMed ID: 29676845 [TBL] [Abstract][Full Text] [Related]
24. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer. Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969 [TBL] [Abstract][Full Text] [Related]
25. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes. Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma. Jiang W; Wu T; Shi X; Xu J Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781 [TBL] [Abstract][Full Text] [Related]
27. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma. Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688 [TBL] [Abstract][Full Text] [Related]
28. Clusterin contributes to hepatitis C virus-related hepatocellular carcinoma by regulating autophagy. Fu N; Du H; Li D; Lu Y; Li W; Wang Y; Kong L; Du J; Zhao S; Ren W; Han F; Wang R; Zhang Y; Nan Y Life Sci; 2020 Sep; 256():117911. PubMed ID: 32504756 [TBL] [Abstract][Full Text] [Related]
29. CFHR3 is a potential novel biomarker for hepatocellular carcinoma. Liu J; Li W; Zhao H J Cell Biochem; 2020 Apr; 121(4):2970-2980. PubMed ID: 31709629 [TBL] [Abstract][Full Text] [Related]
30. The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis. Zhao X; Chen J; Yin S; Shi J; Zheng M; He C; Meng H; Han Y; Han J; Guo J; Yuan Z; Wang Y Front Oncol; 2022; 12():992468. PubMed ID: 36313717 [TBL] [Abstract][Full Text] [Related]
31. Identification of MTCH1 as a novel prognostic indicator and therapeutic target in hepatocellular carcinoma. Xie L; Shu Y; Ye M; Li Y Pathol Res Pract; 2024 Jul; 259():155358. PubMed ID: 38820930 [TBL] [Abstract][Full Text] [Related]
32. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma. Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238 [TBL] [Abstract][Full Text] [Related]
33. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma. Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575 [TBL] [Abstract][Full Text] [Related]
34. Increased expression of Cyclin F in liver cancer predicts poor prognosis: A study based on TCGA database. Zelong Y; Han Y; Ting G; Yifei W; Kun H; Haoran H; Yong C Medicine (Baltimore); 2021 Aug; 100(31):e26623. PubMed ID: 34397798 [TBL] [Abstract][Full Text] [Related]
35. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein]. Wang XJ; Shen RF; Wang X; Wang YR; Xiao T Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029 [No Abstract] [Full Text] [Related]
36. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma. Chen S; Zhao E Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631 [TBL] [Abstract][Full Text] [Related]
37. Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data. Zeng Z; Cao Z; Zhang E; Huang H; Tang Y Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33346796 [TBL] [Abstract][Full Text] [Related]
38. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway. Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361 [TBL] [Abstract][Full Text] [Related]
39. Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma. Gao J; Jia WD Med Sci Monit; 2019 Oct; 25():7826-7835. PubMed ID: 31626606 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G Front Genet; 2022; 13():959832. PubMed ID: 36299588 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]